Ovarian hyperstimulation syndrome: Pathophysiology and prevention

Journal of Assisted Reproduction and Genetics

Volumn 27, Issue 2-3, 2010, Pages 121-128

  Nastri, Carolina O ^a,b   Ferriani, Rui A ^a   Rocha, Isa A ^a   Martins, Wellington P ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Escola de Ultra sonografia de Ribeirao Preto   (Brazil)

Author keywords

Assisted reproductive techniques; Ovarian hyperstimulation syndrome; Ovulation induction

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; CABERGOLINE; CHORIONIC GONADOTROPIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOPAMINE RECEPTOR STIMULATING AGENT; ESTRADIOL; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; HUMAN ALBUMIN; LUTEINIZING HORMONE; MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT; RECOMBINANT LUTEINIZING HORMONE; VASCULOTROPIN;

CLINICAL TRIAL; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG MECHANISM; DRUG SUBSTITUTION; HIGH RISK PATIENT; HUMAN; INFERTILITY THERAPY; LOW DRUG DOSE; NONHUMAN; OOCYTE MATURATION; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENIN ANGIOTENSIN DISORDER; REVIEW; SINGLE DRUG DOSE;

ADULT; ALBUMINS; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELLS, CULTURED; CHORIONIC GONADOTROPIN; DOPAMINE AGONISTS; ESTRADIOL; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKINS; LUTEINIZING HORMONE; OOCYTES; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77952242045     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10815-010-9387-6     Document Type: Review

References (50)

1. A Delvigne S Rozenberg 2002 Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review Hum Reprod Updat 8 559 77 10.1093/humupd/8.6.559 1:CAS:528:DC%2BD38XptlOis78%3D (Pubitemid 35452781)
2. NF Vlahos O Gregoriou 2006 Prevention and management of ovarian hyperstimulation syndrome Ann N Y Acad Sci 1092 247 64 10.1196/annals.1365.021 1:CAS:528:DC%2BD2sXjtlajtro%3D 17308149 (Pubitemid 47092342)
3. Gera PS, Tatpati LL, Allemand MC, Wentworth MA, Coddington CC. Ovarian hyperstimulation syndrome: steps to maximize success and minimize effect for assisted reproductive outcome. Fertil Steril. 2009.
4. R Michaelson-Cohen G Altarescu U Beller R Reens T Halevy-Shalem T Eldar-Geva 2008 Does elevated human chorionic gonadotropin alone trigger spontaneous ovarian hyperstimulation syndrome? Fertil Steril 90 1869 74 10.1016/j.fertnstert.2007.09.049 1:CAS:528:DC%2BD1cXhsVOhurvM 18166181
5. ASRM 2008 Ovarian hyperstimulation syndrome Fertil Steril 90 S188 93
6. MA Aboulghar RT Mansour 2003 Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures Hum Reprod Updat 9 275 89 10.1093/humupd/dmg018 1:STN:280:DC%2BD3szivFWqtg%3D%3D (Pubitemid 36827064)
7. MP Goldsman A Pedram CE Dominguez I Ciuffardi E Levin RH Asch 1995 Increased capillary permeability induced by human follicular fluid: a hypothesis for an ovarian origin of the hyperstimulation syndrome Fertil Steril 63 268 72 1:STN:280:DyaK2M7ksFOnsA%3D%3D 7843429
8. A Tollan N Holst F Forsdahl HO Fadnes P Oian JM Maltau 1990 Transcapillary fluid dynamics during ovarian stimulation for in vitro fertilization Am J Obstet Gynecol 162 554 8 1:STN:280:DyaK3c7nvVejsA%3D%3D 2309842
9. RH Asch HP Li JP Balmaceda LN Weckstein SC Stone 1991 Severe ovarian hyperstimulation syndrome in assisted reproductive technology: definition of high risk groups Hum Reprod 6 1395 9 1:STN:280:DyaK387itFerug%3D%3D 1770133
10. A Pellicer F Miro M Sampaio E Gomez FM Bonilla-Musoles 1991 In vitro fertilization as a diagnostic and therapeutic tool in a patient with partial 17, 20-desmolase deficiency Fertil Steril 55 970 5 1:STN:280:DyaK3M3hs1aruw%3D%3D 1902422
11. SR Soares R Gomez C Simon JA Garcia-Velasco A Pellicer 2008 Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome Hum Reprod Updat 14 321 33 10.1093/humupd/dmn008 1:CAS:528: DC%2BD1cXnt1SksLc%3D (Pubitemid 351858972)
12. B Rizk M Aboulghar J Smitz R Ron-El 1997 The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome Hum Reprod Updat 3 255 66 10.1093/humupd/3.3.255 1:CAS:528:DyaK1MXltVWmt7k%3D (Pubitemid 27437930)
13. D Navot EJ Margalioth N Laufer A Birkenfeld A Relou A Rosler, et al. 1987 Direct correlation between plasma renin activity and severity of the ovarian hyperstimulation syndrome Fertil Steril 48 57 61 1:STN:280:DyaL2s3kslChtw%3D%3D 2439386
14. PJ Blankestijn FH Derkx JA Van Geelen FH De Jong MA Schalekamp 1990 Increase in plasma prorenin during the menstrual cycle of a bilaterally nephrectomized woman Br J Obstet Gynaecol 97 1038 42 1:STN:280: DyaK3M%2FntVSisw%3D%3D 2123712
15. LA Fernandez BC Tarlatzis PJ Rzasa VJ Caride N Laufer AF Negro-Vilar, et al. 1985 Renin-like activity in ovarian follicular fluid Fertil Steril 44 219 23 1:CAS:528:DyaL2MXltFOjtrg%3D 2410302
16. RS Morris RJ Paulson 1999 Increased angiotensin-converting enzyme activity in a patient with severe ovarian hyperstimulation syndrome Fertil Steril 71 562 3 10.1016/S0015-0282(98)00471-3 1:STN:280:DyaK1M7mtlKrsA%3D%3D 10065799 (Pubitemid 29094138)
17. M Manno F Tomei 2008 Renin-angiotensin system activation during severe OHSS: cause or effect? Fertil Steril 89 488 10.1016/j.fertnstert.2007.12.003 18275884 (Pubitemid 351217076)
18. N McClure DL Healy PA Rogers J Sullivan L Beaton RV Haning Jr, et al. 1994 Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome Lancet 344 235 6 10.1016/S0140-6736(94)93001-5 1:STN:280:DyaK2czgtFSrtA%3D%3D 7913160 (Pubitemid 24229013)
19. R Gomez C Simon J Remohi A Pellicer 2003 Administration of moderate and high doses of gonadotropins to female rats increases ovarian vascular endothelial growth factor (VEGF) and VEGF receptor-2 expression that is associated to vascular hyperpermeability Biol Reprod 68 2164 71 10.1095/biolreprod.102.010801 1:CAS:528:DC%2BD3sXks1Ggsb0%3D 12606463 (Pubitemid 36687009)
20. TH Wang SG Horng CL Chang HM Wu YJ Tsai HS Wang, et al. 2002 Human chorionic gonadotropin-induced ovarian hyperstimulation syndrome is associated with up-regulation of vascular endothelial growth factor J Clin Endocrinol Metab 87 3300 8 10.1210/jc.87.7.3300 1:CAS:528:DC%2BD38XlsVGjurw%3D 12107240 (Pubitemid 34816380)
21. A Villasante A Pacheco A Ruiz A Pellicer JA Garcia-Velasco 2007 Vascular endothelial cadherin regulates vascular permeability: Implications for ovarian hyperstimulation syndrome J Clin Endocrinol Metab 92 314 21 10.1210/jc.2006-1231 1:CAS:528:DC%2BD2sXpsVKgtg%3D%3D 17032719 (Pubitemid 46067549)
22. M Rodewald D Herr WC Duncan HM Fraser G Hack R Konrad, et al. 2009 Molecular mechanisms of ovarian hyperstimulation syndrome: paracrine reduction of endothelial claudin 5 by hCG in vitro is associated with increased endothelial permeability Hum Reprod 24 5 1191 9 10.1093/humrep/den479 1:CAS:528:DC%2BD1MXksFejt7Y%3D 19168871
23. LG Nardo P Cheema TA Gelbaya G Horne CT Fitzgerald EH Pease, et al. 2006 The optimal length of 'coasting protocol' in women at risk of ovarian hyperstimulation syndrome undergoing in vitro fertilization Hum Fertil (Camb) 9 175 80 10.1080/14647270600787575 (Pubitemid 44480441)
24. Ho Yuen B, Nguyen TA, Cheung AP, Leung PC: Clinical and endocrine response to the withdrawal of gonadotropin-releasing hormone agonists during prolonged coasting. Fertil Steril. 2008.
25. HS Moon BS Joo SE Moon SK Lee KS Kim JS Koo 2008 Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome Fertil Steril 90 2172 8 10.1016/j.fertnstert.2007.10.033 1:CAS:528:DC%2BD1MXmtlOqtA%3D%3D 18439601
26. Yilmaz N, Uygur D, Ozgu E, Batioglu S: Does coasting, a procedure to avoid ovarian hyperstimulation syndrome, affect assisted reproduction cycle outcome? Fertil Steril. 2009.
27. JA Garcia-Velasco A Zuniga A Pacheco R Gomez C Simon J Remohi, et al. 2004 Coasting acts through downregulation of VEGF gene expression and protein secretion Hum Reprod 19 1530 8 10.1093/humrep/deh298 1:CAS:528: DC%2BD2cXlt1Wlsb0%3D 15155606 (Pubitemid 38997176)
28. D'Angelo A, Amso N: "Coasting" (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome. Cochrane Database Syst Rev. 2002;CD002811.
29. HG Huddleston C Racowsky KV Jackson JH Fox ES Ginsburg 2008 Coasting vs. cryopreservation of all embryos for prevention of ovarian hyperstimulation syndrome in in vitro fertilization Fertil Steril 90 1259 62 10.1016/j. fertnstert.2007.07.1383 18163999
30. M Aboulghar JH Evers H Al-Inany 2002 Intravenous albumin for preventing severe ovarian hyperstimulation syndrome: a Cochrane review Hum Reprod 17 3027 32 10.1093/humrep/17.12.3027 1:CAS:528:DC%2BD3sXltFaitg%3D%3D 12456597
31. M Isikoglu M Berkkanoglu Z Senturk K Ozgur 2007 Human albumin does not prevent ovarian hyperstimulation syndrome in assisted reproductive technology program: a prospective randomized placebo-controlled double blind study Fertil Steril 88 982 5 10.1016/j.fertnstert.2006.11.170 17313946 (Pubitemid 47498350)
32. J Bellver EA Munoz A Ballesteros SR Soares E Bosch C Simon, et al. 2003 Intravenous albumin does not prevent moderate-severe ovarian hyperstimulation syndrome in high-risk IVF patients: a randomized controlled study Hum Reprod 18 2283 8 10.1093/humrep/deg451 1:CAS:528:DC%2BD3sXovVekt7c%3D 14585874 (Pubitemid 37427804)
33. H Ando K Furugori D Shibata T Harata Y Murata S Mizutani 2003 Dual renin-angiotensin blockade therapy in patients at high risk of early ovarian hyperstimulation syndrome receiving IVF and elective embryo cryopreservation: a case series Hum Reprod 18 1219 22 10.1093/humrep/deg268 1:CAS:528: DC%2BD3sXltFygt7o%3D 12773449 (Pubitemid 36740567)
34. B Ata K Yakin C Alatas B Urman 2008 Dual renin-angiotensin blockage and total embryo cryopreservation is not a risk-free strategy in patients at high risk for ovarian hyperstimulation syndrome Fertil Steril 90 531 6 10.1016/j.fertnstert.2007.07.1309 18001715
35. R Gomez M Gonzalez-Izquierdo RC Zimmermann E Novella-Maestre I Alonso-Muriel J Sanchez-Criado, et al. 2006 Low-dose dopamine agonist administration blocks vascular endothelial growth factor (VEGF)-mediated vascular hyperpermeability without altering VEGF receptor 2-dependent luteal angiogenesis in a rat ovarian hyperstimulation model Endocrinology 147 5400 11 10.1210/en.2006-0657 1:CAS:528:DC%2BD28XhtFCgsLjM 16901966 (Pubitemid 44790595)
36. C Carizza V Abdelmassih S Abdelmassih P Ravizzini L Salgueiro PT Salgueiro, et al. 2008 Cabergoline reduces the early onset of ovarian hyperstimulation syndrome: a prospective randomized study Reprod Biomed Online 17 751 5 1:CAS:528:DC%2BD1MXht1ekur4%3D 19079957
37. Varnagy A, Bodis J, Manfai Z, Wilhelm F, Busznyak C, Koppan M: Low-dose aspirin therapy to prevent ovarian hyperstimulation syndrome. Fertil Steril. 2009.
38. R Quintana L Kopcow G Marconi E Young C Yovanovich DA Paz 2008 Inhibition of cyclooxygenase-2 (COX-2) by meloxicam decreases the incidence of ovarian hyperstimulation syndrome in a rat model Fertil Steril 90 1511 6 10.1016/j.fertnstert.2007.09.028 1:CAS:528:DC%2BD1cXhtlSru7zO 18166186
39. HG Al-Inany AM Abou-Setta M Aboulghar 2007 Gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane review Reprod Biomed Online 14 640 9 1:STN:280:DC%2BD2s3pvVSrtA%3D%3D 17509210
40. DW Schmidt DB Maier JC Nulsen CA Benadiva 2004 Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization Fertil Steril 82 841 6 10.1016/j.fertnstert.2004.03.055 1:CAS:528:DC%2BD2MXhvFOjtrs%3D 15482757 (Pubitemid 39346427)
41. G Nargund L Hutchison R Scaramuzzi S Campbell 2007 Low-dose HCG is useful in preventing OHSS in high-risk women without adversely affecting the outcome of IVF cycles Reprod Biomed Online 14 682 5 1:CAS:528:DC%2BD2sXns1aqsbg%3D 17579978
42. TERLS Group 2001 Human recombinant luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: results of a multicenter double-blind study J Clin Endocrinol Metab 86 2607 18 10.1210/jc.86.6.2607 (Pubitemid 32545713)
43. D Bodri JJ Guillen A Galindo D Mataro A Pujol O Coll 2009 Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study Fertil Steril 91 365 71 10.1016/j.fertnstert.2007.11.049 1:CAS:528:DC%2BD1MXnsF2nsLo%3D 18367175
44. A Galindo D Bodri JJ Guillen M Colodron V Vernaeve O Coll 2009 Triggering with HCG or GnRH agonist in GnRH antagonist treated oocyte donation cycles: a randomised clinical trial Gynecol Endocrinol 25 60 6 10.1080/09513590802404013 1:CAS:528:DC%2BD1MXhtVCntLc%3D 19165664
45. L Engmann A DiLuigi D Schmidt J Nulsen D Maier C Benadiva 2008 The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study Fertil Steril 89 84 91 10.1016/j.fertnstert.2007.02.002 1:CAS:528:DC%2BD1cXhslSrsbo%3D 17462639
46. Manzanares MA, Gomez-Palomares JL, Ricciarelli E, Hernandez ER: Triggering ovulation with gonadotropin-releasing hormone agonist in in vitro fertilization patients with polycystic ovaries does not cause ovarian hyperstimulation syndrome despite very high estradiol levels. Fertil Steril. 2009.
47. SE Lanzendorf 2006 Developmental potential of in vitro- and in vivo-matured human oocytes collected from stimulated and unstimulated ovaries Fertil Steril 85 836 7 10.1016/j.fertnstert.2005.09.057 16580358
48. AM Suikkari 2008 In-vitro maturation: its role in fertility treatment Curr Opin Obstet Gynecol 20 242 8 10.1097/GCO.0b013e3282f88e33 18460938 (Pubitemid 351643511)
49. WY Son JT Chung E Demirtas H Holzer C Sylvestre W Buckett, et al. 2008 Comparison of in-vitro maturation cycles with and without in-vivo matured oocytes retrieved Reprod Biomed Online 17 59 67 18616892
50. WY Son JT Chung RC Chian B Herrero E Demirtas S Elizur, et al. 2008 A 38 h interval between hCG priming and oocyte retrieval increases in vivo and in vitro oocyte maturation rate in programmed IVM cycles Hum Reprod 23 2010 6 10.1093/humrep/den210 1:CAS:528:DC%2BD1cXhtF2qtb7P 18556681